Evidence map›Paper›PMID 23253940›Full record

ArticlePigment cell & melanoma research2013

MGRN1-dependent pigment-type switching requires its ubiquitination activity but not its interaction with TSG101 or NEDD4.

Teresa M Gunn, Derek Silvius, Pooneh Bagher, Kaihua Sun, Katherine K Walker

Open access · greenAbstract read
In one paragraph

Article in Pigment cell & melanoma research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Teresa M GunnMcLaughlin Research Institute, Great Falls, MT, USA; Department of Biomedical Sciences, Cornell University, Ithaca, NY, USA. tmg@mri.montana.edu
Derek Silvius
Pooneh Bagher
Kaihua Sun
Katherine K Walker
McLaughlin Research Institute · USCornell University · US

Funding

Functional analysis of Attractin-Mahogunin signalingR01AG022058 · NIA · CORNELL UNIVERSITY ITHACA · PI GUNN, TERESA M · 2003 to 2007
$1.9M
NIA NIH HHS R01 AG022058NIA NIH HHS R01AG022058
6 · The paper itself

Abstract

Mice lacking the E3 ubiquitin ligase mahogunin ring finger-1 (MGRN1) have a pleiotropic phenotype that includes spongiform neurodegeneration, embryonic patterning defects, and dark fur due to a defect in pigment-type switching. The only MGRN1 ubiquitination target identified to date is tumor susceptibility gene 101 (TSG101), a component of the endosomal trafficking machinery. Here, we show that MGRN1 also interacts with but does not ubiquitinate NEDD4, a HECT-domain ubiquitin ligase involved in endosomal trafficking. Using transgenesis in mice, we demonstrate that pigment-type switching likely requires MGRN1's ubiquitin ligase activity but not its ability to bind TSG101 or NEDD4. This indicates that MGRN1-dependent ubiquitination of an as-yet unidentified target protein is required for agouti-mediated melanocortin signaling.

Indexed as

PigmentationUbiquitinationAnimalsDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportHEK293 CellsHumansMiceMice, TransgenicNedd4 Ubiquitin Protein LigasesProtein BindingSkin PigmentationTranscription FactorsTransgenesTsg101 ProteinUbiquitin-Protein LigasesDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportMgrn1 protein, mouseNedd4l protein, mouseNedd4 protein, humanNedd4 Ubiquitin Protein LigasesTranscription FactorsTsg101 ProteinUbiquitin-Protein Ligases

Identifiers

PMID23253940
PMCPMC4226269
OpenAlexW2044755325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.